<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10320192</article-id>
    <article-id pub-id-type="pmid">37216595</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkad425</article-id>
    <article-id pub-id-type="publisher-id">gkad425</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Web Server Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>CRISPRimmunity: an interactive web server for CRISPR-associated Important Molecular events and Modulators Used in geNome edIting Tool identifYing</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Zhou</surname>
          <given-names>Fengxia</given-names>
        </name>
        <!--fengxiazhou_hit@163.com-->
        <aff><institution>HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology</institution>, <addr-line>Harbin</addr-line> 150080, <country country="CN">China</country></aff>
        <xref rid="COR3" ref-type="corresp"/>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0004-9829-2028</contrib-id>
        <name>
          <surname>Yu</surname>
          <given-names>Xiaorong</given-names>
        </name>
        <aff><institution>HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology</institution>, <addr-line>Harbin</addr-line> 150080, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gan</surname>
          <given-names>Rui</given-names>
        </name>
        <aff><institution>Changping Laboratory</institution>, <addr-line>Yard 28, Science Park Road, Changping District, Beijing</addr-line> 102200, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ren</surname>
          <given-names>Kuan</given-names>
        </name>
        <aff><institution>HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology</institution>, <addr-line>Harbin</addr-line> 150080, <country country="CN">China</country></aff>
        <xref rid="FN1" ref-type="author-notes"/>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Chen</surname>
          <given-names>Chuangeng</given-names>
        </name>
        <aff><institution>HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology</institution>, <addr-line>Harbin</addr-line> 150080, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ren</surname>
          <given-names>Chunyan</given-names>
        </name>
        <aff><institution>Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School</institution>, <addr-line>Boston, MA</addr-line> 02115, <country country="US">USA</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cui</surname>
          <given-names>Meng</given-names>
        </name>
        <aff><institution>HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology</institution>, <addr-line>Harbin</addr-line> 150080, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Yuchen</given-names>
        </name>
        <aff><institution>HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology</institution>, <addr-line>Harbin</addr-line> 150080, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Gao</surname>
          <given-names>Yiyang</given-names>
        </name>
        <aff><institution>HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology</institution>, <addr-line>Harbin</addr-line> 150080, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Shouyu</given-names>
        </name>
        <aff><institution>HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology</institution>, <addr-line>Harbin</addr-line> 150080, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Yin</surname>
          <given-names>Mingyu</given-names>
        </name>
        <aff><institution>HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology</institution>, <addr-line>Harbin</addr-line> 150080, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Huang</surname>
          <given-names>Tengjin</given-names>
        </name>
        <aff><institution>HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology</institution>, <addr-line>Harbin</addr-line> 150080, <country country="CN">China</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8201-9391</contrib-id>
        <name>
          <surname>Huang</surname>
          <given-names>Zhiwei</given-names>
        </name>
        <!--huangzhiwei@hit.edu.cn-->
        <aff><institution>HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology</institution>, <addr-line>Harbin</addr-line> 150080, <country country="CN">China</country></aff>
        <aff><institution>Westlake Center for Genome Editing, Westlake Laboratory of Life Sciences and Biomedicine, School of Life Sciences, Westlake University</institution>, <addr-line>Hangzhou, Zhejiang</addr-line> 310024, <country country="CN">China</country></aff>
        <aff><institution>New Cornerstone Science Laboratory</institution>, <addr-line>Shenzhen</addr-line> 518054, <country country="CN">China</country></aff>
        <xref rid="COR2" ref-type="corresp"/>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Zhang</surname>
          <given-names>Fan</given-names>
        </name>
        <!--fanzhang@hit.edu.cn-->
        <aff><institution>HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology</institution>, <addr-line>Harbin</addr-line> 150080, <country country="CN">China</country></aff>
        <aff><institution>Anhui Province Key Laboratory of Medical Physics and Technology, Institute of Health and Medical Technology, Hefei Institutes of Physical Science, Chinese Academy of Sciences</institution>, <addr-line>Hefei</addr-line> 230031, <country country="CN">China</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +86 451 86402010; Fax: +86 451 86402010; Email: <email>fanzhang@hit.edu.cn</email></corresp>
      <corresp id="COR2">Correspondence may also be addressed to Zhiwei Huang. Tel: +86 451 86403163; Fax: +86 451 86403163; Email: <email>huangzhiwei@hit.edu.cn</email></corresp>
      <corresp id="COR3">Correspondence may also be addressed to Fengxia Zhou. Tel: +86 451 86402010; Fax: +86 451 86402010; Email: <email>fengxiazhou_hit@163.com</email></corresp>
      <fn id="FN1">
        <p>The authors wish it to be known that, in their opinion, the first four authors should be regarded as joint First Authors.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="collection">
      <day>05</day>
      <month>7</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2023-05-22">
      <day>22</day>
      <month>5</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>22</day>
      <month>5</month>
      <year>2023</year>
    </pub-date>
    <volume>51</volume>
    <issue>W1</issue>
    <fpage>W93</fpage>
    <lpage>W107</lpage>
    <history>
      <date date-type="accepted">
        <day>10</day>
        <month>5</month>
        <year>2023</year>
      </date>
      <date date-type="rev-recd">
        <day>26</day>
        <month>4</month>
        <year>2023</year>
      </date>
      <date date-type="received">
        <day>26</day>
        <month>3</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkad425.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>The CRISPR-Cas system is a highly adaptive and RNA-guided immune system found in bacteria and archaea, which has applications as a genome editing tool and is a valuable system for studying the co-evolutionary dynamics of bacteriophage interactions. Here introduces CRISPRimmunity, a new web server designed for Acr prediction, identification of novel class 2 CRISPR-Cas loci, and dissection of key CRISPR-associated molecular events. CRISPRimmunity is built on a suite of CRISPR-oriented databases providing a comprehensive co-evolutionary perspective of the CRISPR-Cas and anti-CRISPR systems. The platform achieved a high prediction accuracy of 0.997 for Acr prediction when tested on a dataset of 99 experimentally validated Acrs and 676 non-Acrs, outperforming other existing prediction tools. Some of the newly identified class 2 CRISPR-Cas loci using CRISPRimmunity have been experimentally validated for cleavage activity in <italic toggle="yes">vitro</italic>. CRISPRimmunity offers the catalogues of pre-identified CRISPR systems to browse and query, the collected resources or databases to download, a well-designed graphical interface, a detailed tutorial, multi-faceted information, and exportable results in machine-readable formats, making it easy to use and facilitating future experimental design and further data mining. The platform is available at <ext-link xlink:href="http://www.microbiome-bigdata.com/CRISPRimmunity" ext-link-type="uri">http://www.microbiome-bigdata.com/CRISPRimmunity</ext-link>. Moreover, the source code for batch analysis are published on Github (<ext-link xlink:href="https://github.com/HIT-ImmunologyLab/CRISPRimmunity" ext-link-type="uri">https://github.com/HIT-ImmunologyLab/CRISPRimmunity</ext-link>).</p>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="ga1">
          <label>Graphical Abstract</label>
          <graphic xlink:href="gkad425figgra1" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Natural Science Foundation of China</institution>
            <institution-id institution-id-type="DOI">10.13039/501100001809</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>61872117</award-id>
        <award-id>31825008</award-id>
        <award-id>31422014</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Tencent Foundation through the XPLORER PRIZE and the New Cornerstone Science Foundation</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Heilongjiang Touyan Team</institution>
          </institution-wrap>
        </funding-source>
        <award-id>HITTY-20190034</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="15"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>The CRISPR-Cas systems are not only fascinating systems to study the adaptive immunity of prokaryotes against viral infection, but also have been extensively investigated for their applications in the development of powerful genome editing tools. In the decade since CRISPR-Cas9 was introduced as a genome editing technology, the field of gene editing has undergone transformative advancements in basic research and clinical applications (<xref rid="B1" ref-type="bibr">1</xref>). The advent of programmable genome editing technologies has enabled the application of disease-specific diagnostics and cell and gene therapies (<xref rid="B2" ref-type="bibr">2–6</xref>). Among these technologies, CRISPR-Cas9 and CRISPR-Cas12a, which are derived from bacterial immune systems, are the most widely used genome editing enzymes that use an RNA-guided mechanism to target and cleave DNA sequences (<xref rid="B7" ref-type="bibr">7</xref>,<xref rid="B8" ref-type="bibr">8</xref>). However, their high frequency of off-target effects (≥50%) is an obstacle for their application in the therapeutic and clinical application (<xref rid="B9" ref-type="bibr">9</xref>). Fortunately, viruses have evolved multiple anti-defense mechanisms to specifically inhibit CRISPR activity, such as diverse anti-CRISPR proteins (Acrs), which have enormous potential to be developed as modulators of genome editing tools (<xref rid="B10" ref-type="bibr">10</xref>,<xref rid="B11" ref-type="bibr">11</xref>).</p>
    <p>Recent discoveries of new CRISPR-based enzymes, CRISPR-associated enzymes and anti-CRISPR proteins has greatly enhanced our understanding of the CRISPR-Cas system's role in microbes and its utility for genome editing in other cells and organisms (<xref rid="B12" ref-type="bibr">12</xref>). Several databases have emerged to provide both known and predicted information for CRISPR and anti-CRISPR proteins (Table <xref rid="tbl1" ref-type="table">1</xref>), and several web servers have been developed to predict and characterize the CRISPR-Cas and anti-CRISPR systems (Table <xref rid="tbl2" ref-type="table">2</xref>). However, these resources often only focus on specific areas of CRISPR-related research and provide limited information and services. Additionally, there is currently no available tool for identifying novel class 2 CRISPR-Cas loci. It is imperative to have comprehensive data combined with multi-perspective mining to improve our understanding of RNA-guided DNA/RNA cleavage systems, but such comprehensive online resources or web servers are still lacking.</p>
    <table-wrap position="float" id="tbl1">
      <label>Table 1.</label>
      <caption>
        <p>CRISPR-Cas and anti-CRISPR proteins databases and their features</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th rowspan="1" colspan="1"/>
            <th rowspan="1" colspan="1"/>
            <th colspan="2" align="center" rowspan="1">Cas Protein</th>
            <th colspan="2" align="center" rowspan="1">Acr</th>
            <th rowspan="1" colspan="1"/>
            <th rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <th rowspan="1" colspan="1">Name</th>
            <th rowspan="1" colspan="1">CRISPR array</th>
            <th rowspan="1" colspan="1">EV</th>
            <th rowspan="1" colspan="1">PE</th>
            <th rowspan="1" colspan="1">EV</th>
            <th rowspan="1" colspan="1">PE</th>
            <th rowspan="1" colspan="1">Aca</th>
            <th rowspan="1" colspan="1">IP</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">CRISPRminer (<xref rid="B19" ref-type="bibr">19</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CRISPRCasDB (<xref rid="B20" ref-type="bibr">20</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CasPDB (<xref rid="B21" ref-type="bibr">21</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">Anti-CRISPRdb (<xref rid="B13" ref-type="bibr">13</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">AcrDB (<xref rid="B15" ref-type="bibr">15</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">AcrHub (<xref rid="B59" ref-type="bibr">59</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">AcrCatalog (<xref rid="B60" ref-type="bibr">60</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>CRISPRimmunity (TP)</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="T1TFN1">
          <p>Note: EV: experimentally validated protein; PE: predicted proteins; IP: interacting phage;</p>
        </fn>
        <fn id="T1TFN2">
          <p>TP: this paper.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap position="float" id="tbl2">
      <label>Table 2.</label>
      <caption>
        <p>Computational pipelines for CRISPR-Cas and anti-CRISPR systems prediction</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th rowspan="1" colspan="1"/>
            <th colspan="6" align="center" rowspan="1">Key molecular events</th>
            <th colspan="4" align="center" rowspan="1">Acr prediction</th>
            <th rowspan="1" colspan="1"/>
            <th rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <th rowspan="1" colspan="1">Name</th>
            <th rowspan="1" colspan="1">CA</th>
            <th rowspan="1" colspan="1">CP</th>
            <th rowspan="1" colspan="1">RT</th>
            <th rowspan="1" colspan="1">CLC</th>
            <th rowspan="1" colspan="1">PD</th>
            <th rowspan="1" colspan="1">IMD</th>
            <th rowspan="1" colspan="1">AH</th>
            <th rowspan="1" colspan="1">GA</th>
            <th rowspan="1" colspan="1">ST</th>
            <th rowspan="1" colspan="1">ML</th>
            <th rowspan="1" colspan="1">NE</th>
            <th rowspan="1" colspan="1">RP</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td rowspan="1" colspan="1">CRISPRminer (<xref rid="B19" ref-type="bibr">19</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">WB ROD</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CRISPRCasFinder (<xref rid="B34" ref-type="bibr">34</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">WB SP ROD</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CRISPRidentify (<xref rid="B35" ref-type="bibr">35</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">SP</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">CRISPRone (<xref rid="B61" ref-type="bibr">61</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">WB RA</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">STSS (<xref rid="B26" ref-type="bibr">26</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">SP RD</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">AcrFinder (<xref rid="B14" ref-type="bibr">14</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">WB ROD</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">AcRanker (<xref rid="B39" ref-type="bibr">39</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">WB SP NA</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">PreAcrs (<xref rid="B62" ref-type="bibr">62</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">SP RD</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">PaCRISPR (<xref rid="B30" ref-type="bibr">30</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">WB RD</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">DeepAcr (<xref rid="B63" ref-type="bibr">63</xref>)</td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>×</bold>
            </td>
            <td rowspan="1" colspan="1">SP RD</td>
          </tr>
          <tr>
            <td rowspan="1" colspan="1">
              <bold>CRISPRimmunity (TP)</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">
              <bold>√</bold>
            </td>
            <td rowspan="1" colspan="1">WB SP ROD</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="T2TFN1">
          <p>Note: CA: CRISPR array detection; CP: Cas protein annotation; RT: repeat type annotation;</p>
        </fn>
        <fn id="T2TFN2">
          <p>CLC: classification for CRISPR-Cas system; PD: prophage detection; IMD: interacting MGE detection; AH: Acr homologs; GA: guilt by association; ST: self-targeting in prophage; ML: machine learning;</p>
        </fn>
        <fn id="T2TFN3">
          <p>NE: novel class 2 effector prediction; RP: resource provided; SP: standalone package;</p>
        </fn>
        <fn id="T2TFN4">
          <p>WB: web server; TP: this paper; NA: data or database resource cannot be available;</p>
        </fn>
        <fn id="T2TFN5">
          <p>RO: data or database resource can be browsing by online;</p>
        </fn>
        <fn id="T2TFN6">
          <p>RD: data or database resource can be available by downloading;</p>
        </fn>
        <fn id="T2TFN7">
          <p>ROD: data or database resource can be available by online or downloading.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <p>Here, we present CRISPRimmunity (CRISPR-associated Important Molecular events and Modulators Used in geNome edIting Tool identifYing), a new web server designed to facilitate CRISPR-oriented discovery. This platform improves the accuracy of Acr prediction by integrating a ‘self-targeting’ (ST), ‘guilt by association’ and machine learning approach. Meanwhile, CRISPRimmunity can identify novel class 2 CRISPR-Cas loci through a comparative genomics screening approach, and several identified candidates have been experimentally validated for in <italic toggle="yes">vitro</italic> cleavage activity. In addition, CRISPRimmunity is able to dissect the important molecular events during the co-evolution of CRISPR and anti-CRISPR mechanisms, including CRISPR-Cas system detection and classification, Acr and Acr-associated (Aca) protein annotation, ST spacer search (STSS), repeat classification, prophage detection, and bacteria-phage interaction detection. CRISPRimmunity can be utilized either as a web server (<ext-link xlink:href="http://www.microbiome-bigdata.com/CRISPRimmunity" ext-link-type="uri">http://www.microbiome-bigdata.com/CRISPRimmunity</ext-link>) without registration for general users to study individual input sequences or as a stand-alone tool (<ext-link xlink:href="https://github.com/HIT-ImmunologyLab/CRISPRimmunity" ext-link-type="uri">https://github.com/HIT-ImmunologyLab/CRISPRimmunity</ext-link>) to perform batch analysis.</p>
  </sec>
  <sec sec-type="materials|methods" id="SEC2">
    <title>MATERIALS AND METHODS</title>
    <sec id="SEC2-1">
      <title>Input data requirements and navigation of CRISPRimmunity</title>
      <p>CRISPRimmunity is a user-friendly website that provides three functional modules for annotating key CRISPR-associated molecular events, predicting Acr, and identifying novel class 2 CRISPR-Cas loci. A genome file in (multi-)FASTA or (multi-)GenBank format is required as input data for all modules. The website is divided into three main areas: The top area with buttons for various functions, including viewing historical results (‘MY JOBS’), accessing a detailed manual (‘HELP’), annotating important molecular events (‘ANNOTATION’), predicting Acrs (‘PREDICT’→‘PREDICT ACR’), identifying novel class 2 CRISPR-Cas loci (‘PREDICT’→‘PREDICT NOVEL EFFECTER PROTEIN’), browsing and querying pre-identified CRISPR-Cas events on 18 408 completely sequenced bacterial strains (BROWSE), searching the CRISPR-related results on 235 Acr-containing microbial strains (CASE STUDY), and downloading the CRISPR annotation results for 208 209 human gut microbes and CRISPRimmunity underlying databases for stand-alone version (DOWNLOAD) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1A</xref>); the middle section displays a graphical mechanism or procedure for each functional module (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1B</xref>); while the bottom section contains a module execution panel where users can view examples, upload input data, set parameters, and submit new tasks (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S1C</xref>). User data is kept on the server for one month, ensuring easy access to historical results.</p>
    </sec>
    <sec id="SEC2-2">
      <title>Creation of custom CRISPR-oriented databases</title>
      <p><italic toggle="yes">Database of known Acrs and Acas (AcrsDB and AcasDB)</italic>. CRISPRimmunity collected 136 Acrs from the Anti-CRISRdb (<xref rid="B13" ref-type="bibr">13</xref>) and 49 published Acas from AcrFinder (<xref rid="B14" ref-type="bibr">14</xref>) and AcrDB (<xref rid="B15" ref-type="bibr">15</xref>), and created the AcrsDB and AcasDB using the Diamond suite (<xref rid="B16" ref-type="bibr">16</xref>).</p>
      <p><italic toggle="yes">HTH domain database (HTHDB)</italic>. CRISPRimmunity collected 166 HTH related profiles from the conserved domain database (CDD) of NCBI (<xref rid="B17" ref-type="bibr">17</xref>) based on the keyword ‘HTH’, and built an HTH position-specific score matrices (PSSMs) for rapid identification of HTH domain-containing proteins via RPS-BLAST (<xref rid="B18" ref-type="bibr">18</xref>).</p>
      <p><italic toggle="yes">Cas protein HMM database (CasDB)</italic>. CRISPRimmunity collected 437 Cas protein sequences from CRISPRminer (<xref rid="B19" ref-type="bibr">19</xref>), CRISPRCasDB (<xref rid="B20" ref-type="bibr">20</xref>), CasPDB (<xref rid="B21" ref-type="bibr">21</xref>) and literature searches via the PubMed and Google Scholar websites (<xref rid="B22" ref-type="bibr">22–24</xref>) and constructed the CasDB using the HMMER suite (<xref rid="B25" ref-type="bibr">25</xref>).</p>
      <p><italic toggle="yes">Database of repeat with known CRISPR-system type (RepeatDB)</italic>. CRISPRimmunity collected 54 distinguishable repeat sequences for various CRISPR types from the Self-targeting-Spacer-Searcher (<xref rid="B26" ref-type="bibr">26</xref>), and built the RepeatDB using the HMMER suite (<xref rid="B25" ref-type="bibr">25</xref>).</p>
      <p><italic toggle="yes">MGE genome database (MGEDB)</italic>. CRISPRimmunity downloaded 52 369 plasmids, phage and archaeal viruses from the NCBI Microbial Genomes Portal in April 2021 (<xref rid="B27" ref-type="bibr">27</xref>), 46 600 non-redundant genomes, obtained by CD-HIT-EST (<xref rid="B28" ref-type="bibr">28</xref>) with the parameter "-n 5 -c 1 -aS 1’, was curated to build a BLASTN (<xref rid="B29" ref-type="bibr">29</xref>) database for MGE-targeting analysis.</p>
      <p><italic toggle="yes">Acr and non-Acr datasets</italic>. CRISPRimmunity totally collected 99 experimentally validated Acrs from Anti-CRISRdb (<xref rid="B13" ref-type="bibr">13</xref>), and 676 non-Acrs from 3 phage and bacteria MGE datasets described in previously study (<xref rid="B30" ref-type="bibr">30</xref>), and fetched the genome sequences of corresponding strains in the custom pipeline using Biopython (<xref rid="B31" ref-type="bibr">31</xref>).</p>
    </sec>
    <sec id="SEC2-3">
      <title>Functional module 1: important CRISPR-related molecular events annotation program</title>
      <p>CRISPRimmunity dissects the important molecular events involved in the co-evolution of CRISPR and anti-CRISPR mechanisms, including CRISPR-Cas system classification, Acr and Aca protein annotation, STSS, repeat classification, prophage detection, and bacteria-phage interaction detection, to facilitate the users with diverse needs.</p>
      <p><italic toggle="yes">CRISPR array identification</italic>. CRISPRimmunity integrates multiple strategies for identifying CRISPR arrays, including searching for repetitive patterns and using machine learning techniques. A combination of PILER-CR (<xref rid="B32" ref-type="bibr">32</xref>), CRT (<xref rid="B33" ref-type="bibr">33</xref>), CRISPRCasFinder (<xref rid="B34" ref-type="bibr">34</xref>) and CRISPRidentify (<xref rid="B35" ref-type="bibr">35</xref>) are incorporated to provide a thorough analysis of CRISPR arrays, and integrated and individual results are available for further analysis.</p>
      <p><italic toggle="yes">Protein sequence extraction</italic>. Prodigal (<xref rid="B36" ref-type="bibr">36</xref>) is utilized with the ‘-p meta’ parameter to extract proteins from a FASTA format genome, and a custom pipeline based on Biopython (<xref rid="B31" ref-type="bibr">31</xref>) is employed for a Genbank format genome.</p>
      <p><italic toggle="yes">Annotation of CRISPR Cas protein and repeat type</italic>. Proteins within the user-specified distance to the CRISPR array (default: 20 kb) were annotated as the best hit by comparing with <italic toggle="yes">CasDB</italic> using hmmscan (<xref rid="B25" ref-type="bibr">25</xref>) with a threshold <italic toggle="yes">e</italic>-value &lt;1e−9. Repeat type was predicted by <italic toggle="yes">RepeatDB</italic> with a threshold <italic toggle="yes">e</italic>-value &lt;1e−6.</p>
      <p><italic toggle="yes">Detection of ST events</italic>. CRISPRimmunity detects ST events by utilizing BLASTN (<xref rid="B29" ref-type="bibr">29</xref>) to compare the spacer sequence with the input genome, with the parameter ‘-task blastn-short -word_size 7 -penalty -1 -reward 1’, filtering out hits with too many mismatches or less coverage (default: mismatch = 2, coverage = 1), or occurring within the CRISPR array.</p>
      <p><italic toggle="yes">Detection of MGE-targeting event</italic>. CRISPRimmunity identifies MGE-targeting events by employing BLASTN (<xref rid="B29" ref-type="bibr">29</xref>) to compare the spacer sequence with MGEDB, with the parameter ‘-task blastn-short -word_size 7 -gapopen 10 -penalty -1 -gapextend 2 -ungapped’, while filtering out hits based on user-specified thresholds (default: mismatch = 2, coverage = 0.9). Additionally, CRISPRimmunity provides a multiple alignment result between spacer and target sequences for user convenience using MAFFT (<xref rid="B37" ref-type="bibr">37</xref>) with default parameters.</p>
      <p><italic toggle="yes">Detection of prophage region</italic>. CRISPRimmunity utilizes DBSCAN-SWA (<xref rid="B38" ref-type="bibr">38</xref>) (a custom prophage detection tool) with default parameters to predict prophage regions in the input genome based on phage-like protein and integration-related features.</p>
    </sec>
    <sec id="SEC2-4">
      <title>Functional module 2: Acr prediction procedure</title>
      <p>CRISPRimmunity integrates three strategies: searching for known Acr homologs, guilt by association analysis and self-targeting in prophage optimization to predict Acrs.</p>
      <p><italic toggle="yes">Searching for known Acr homologs</italic>. CRISPRimmunity extracts proteins from the input sequence and compares them with AcrsDB using Diamond BLASTP(16) with default parameters. The identified Acr homologs are then functionally annotated by comparing with CDD using RPSBLAST (<xref rid="B18" ref-type="bibr">18</xref>) with a threshold e-value &lt;0.01. Proteins with unknown function or &lt;400 aa in size are preliminarily screened as candidates. Subsequently, the candidates are compared to published Acrs based on amino acid sequence, and those with a similarity higher than 90% are excluded.</p>
      <p><italic toggle="yes">Guilt by association analysis</italic>. CRISPRimmunity compares the proteins extracted from the input sequence to AcasDB. The user-specified upstream and downstream neighbors of the Aca homologs (default: 3) are functionally annotated. Next, Acr candidates are screened using the same parameters as previously described in ‘<italic toggle="yes">Searching for known Acr homologs</italic>’.</p>
      <p><italic toggle="yes">Optimizing using self-targeting events in prophage</italic>. CRISPRimmunity adopts two strategies to predict Acrs in prophage. For prophage containing ST, CRISPRimmunity compares all proteins in the prophage to HTHDB for searching HTH-domain containing proteins as potential Aca using RPSBLAST (<xref rid="B18" ref-type="bibr">18</xref>) with a threshold <italic toggle="yes">e</italic>-value &lt;0.01. Acr candidates are then predicted as described in ‘guilt by association analysis’. For prophage not containing ST, Acr candidates are screened out by the probability of being an Acr predicted with AcRanker (<xref rid="B39" ref-type="bibr">39</xref>).</p>
    </sec>
    <sec id="SEC2-5">
      <title>Functional module 3: novel class 2 CRISPR-cas loci detection pipeline</title>
      <p>CRISPRimmunity detects orphan CRISPR(s) without any published CRISPR effector in the input genome, and exclude potential degenerated or shared CRISPR-Cas loci by comparing the repeat sequence with RepeatDB using hmmscan (<xref rid="B25" ref-type="bibr">25</xref>) with a threshold <italic toggle="yes">e</italic>-value &lt;1e−6 and self-genome using BLASTN (<xref rid="B29" ref-type="bibr">29</xref>) with the parameter ‘-task blastn-short -word_size 7 -gapopen 10 -penalty -1 -gapextend 2’.</p>
      <p>Next, CRISPRimmunity extracts the proteins located near the retained orphan CRISPR(s) based on a user-defined number (default of 5). Function of those proteins are annotated by comparing with CDD using RPSBLAST (<xref rid="B19" ref-type="bibr">19</xref>) with a threshold <italic toggle="yes">e</italic>-value &lt;0.01. Initial candidates are chosen based on user-specified size (default of 500 aa) and the presence of a nuclease-associated domain. Because the CRISPR-Cas system evolved to resist phage invasion and similar systems can be observed in multiple strains and species, we analyze whether homologs of the initial candidates appear consistently next to the CRISPR array. To be considered as a final candidate, there must be at least three homologous proteins that appear stably next to the CRISPR array, with &lt;90% similarity.</p>
      <p>Finally, CRISPRimmunity visualizes the evolutionary relationship between candidate(s) and previously published class 2 CRISPR-Cas effectors. A maximum likelihood tree is constructed by FastTree (<xref rid="B40" ref-type="bibr">40</xref>) with default parameters based on the multiple alignment result by MAFFT (<xref rid="B37" ref-type="bibr">37</xref>) with default parameters. The resulting phylogenetic tree is then visualized using the R package ggtree (<xref rid="B41" ref-type="bibr">41</xref>).</p>
    </sec>
    <sec id="SEC2-6">
      <title>User interface and system features</title>
      <p><italic toggle="yes">System implementation</italic>. The CRISPRimmunity web server is implemented using Django, a high-level Python web framework, and incorporates a well-designed graphical user interface and detailed tutorials for helping features navigation and results interpretation. The web interface ensures a fast rendering and high performance through JavaScript library integration. Additionally, the CRISPRimmunity web server supports all major internet browsers.</p>
      <p><italic toggle="yes">System features</italic>. CRISPRimmunity provides a concise table and interactive viewer for displaying important features of protein and CRISPR-Cas loci. A Circle plot is used to intuitively represents key molecular events and anti-CRISPR proteins, with each entity represented by a unique color, and detailed information can be obtained by clicking on the entity. A maximum likelihood tree constructed using FastTree (<xref rid="B40" ref-type="bibr">40</xref>) characterizes the evolutionary relationship between the candidate(s) and the previously published class 2 CRISPR-Cas effectors. The export option is equipped to export key results in various machine-readable formats for further analysis. The platform also allows for online browsing and querying of pre-identified CRISPR-associated events on the 18 408 completely sequenced bacterial strains and 235 Acr-containing bacteria strains from NCBI, with the option to sort or screen results based on events of interest or CRISPR-system type. Detailed information can be obtained by clicking the ‘View’ button. Additionally, CRISPRimmunity provides a download option for CRISPR-related results from 18 408 completely sequenced bacterial strains and 208 209 human gut microbes, as well as various CRISPR-oriented databases collected by this study.</p>
    </sec>
    <sec id="SEC2-7">
      <title>Protein expression and purification</title>
      <p>Full-length Cj2Cas9 cDNA was sub-cloned into the bacterial expression vector pGEX-6P-1. Cj2Cas9 protein was expressed in <italic toggle="yes">E. coli</italic> C43 (DE3) cells and purified as previously described previously (<xref rid="B42" ref-type="bibr">42</xref>). Cj2Cas9 expression was induced by 0.3 mM IPTG at 16°C. After overnight induction, cells were collected by centrifugation. Cj2Cas9 was resuspended in buffer (25 mM Tris–HCl, pH 8.0, 1 M NaCl, 3 mM DTT). Cells were disrupted by sonication and cell debris was removed by centrifugation. The lysate was purified using glutathione sepharose 4B (GS4B) beads. The bound proteins were cleaved with precision protease overnight at 4°C to remove the GST tag. The cleaved Cj2Cas9 protein was eluted from the GS4B resin and further fractionated by heparin sepharose column and ion exchange chromatography via FPLC (AKTA Pure, GE Healthcare).</p>
    </sec>
    <sec id="SEC2-8">
      <title><italic toggle="yes">In vitro</italic> transcription and purification of sgRNA</title>
      <p>The sgRNAs were transcribed <italic toggle="yes">in vitro</italic> using home-made T7 polymerase and purified by gel electrophoresis as previously described (<xref rid="B42" ref-type="bibr">42</xref>). The transcription template was generated by PCR. RNA was purified by gel electrophoresis on a denaturing (8 M urea) polyacrylamide gel and recovered using the Elutrap System followed by ethanol precipitation. RNAs were resuspended in DEPC H2O and stored at –80°C.</p>
    </sec>
    <sec id="SEC2-9">
      <title>PAM characterization</title>
      <p>To characterize PAM, a plasmid library, which was constructed as previously described (<xref rid="B43" ref-type="bibr">43</xref>), containing 7-bp randomized nucleotides located at the immediately 3′ downstream of the target sequence. Reactions were performed in a 50 μL system containing 500 nM RNP complex and 2 μg PAM library plasmid. Cleavage reactions were performed at 37°C for 60 minutes in cleavage buffer (20 mM HEPES–Na, pH 7.5, 2 mM MgCl<sub>2</sub>, 100 mM KCl, 1 mM dithiothreitol, 5% glycerol). The 3′dA overhang was added by incubating the cleaved product with A-tailing kit (TAKARA). The A-tailing products (100 ng) were ligated with a dsDNA adapter containing a 3′-dT overhang (100 ng) at 16°C for 1 h. After ligation, the adapter-bearing cleavage products were PCR-amplified for the addition of sequences required for deep sequencing and subjected to Illumina sequencing offered by the HI-TOM platform (<ext-link xlink:href="http://121.40.237.174/Hi-TOM/" ext-link-type="uri">http://121.40.237.174/Hi-TOM/</ext-link>) (<xref rid="B44" ref-type="bibr">44</xref>).</p>
    </sec>
    <sec id="SEC2-10">
      <title>In vitro DNA cleavage assay</title>
      <p>Target DNA sequences were cloned into pUC19 vector using BamH1 and EcoR1 and dsDNA substrates were generated by PCR assay using pUC19 primers. Target DNA sequences contain a PAM sequence of 3′ -G motif at the 3′ downstream of the 20-nt target sequence.</p>
      <p>The DNA cleavage assay was performed in a 20 μl system containing 0.5 μg Cj2Cas9, 0.1 μg sgRNA and 0.2 μg plasmid or dsDNA at 37 °C. Cj2Cas9 and sgRNA were pre-incubated in cleavage buffer for 5 min at room temperature. The plasmid cleavage reactions were stopped at different time points (5 min, 15 min and 30min) respectively by adding 6×  DNA gel loading buffer. Plasmid cleavage products were run on 1% agarose gel at room temperature and visualized by EB staining. The dsDNA cleavage reactions were stopped by adding 2×  TBE–urea gel loading buffer. Cleavage products were run on 6% TBE–urea PAGE at room temperature in 1×  TBE running buffer and visualized by EB staining.</p>
    </sec>
  </sec>
  <sec sec-type="results" id="SEC3">
    <title>RESULTS</title>
    <sec id="SEC3-1">
      <title>Anti-CRISPR protein (Acr) prediction</title>
      <p>We integrate three strategies to predict Acrs based on protein sequence features, cassette features of neighboring proteins, and genomic features including prophage and self-targeting. The first strategy involves searching for homologs of known Acrs to identify potential candidates that may serve as more effective CRISPR switches. We then screen the predicted Acr candidates based on protein size, functional domain, and similarity to known Acrs. This approach is based on the hypothesis that Acrs inhibiting the same type of CRISPR-Cas systems will share similar sequence features. The second strategy employs the concept of guilt by association to infer candidates for Acr by tracing potential Aca proteins that commonly locatedadjacent to the Acr in a cassette. We first infer the candidate Aca(s) based on homology to known Aca(s), and subsequently screen the Aca neighbor proteins for the same protein sequence features used in the first strategy to predict Acr candidates. This approach is based on the observation that Aca(s) typically locate downstream of the Acr and likely play a role in regulating the activity of the Acr (<xref rid="B45" ref-type="bibr">45</xref>). The third strategy involves identifying self-targeting events within prophage as a strong indicator of the existence of Acrs. We identify prophage regions with self-targeting events and screen the intraregional proteins using the first two strategies (homologies and guilt by association). Additionally, we utilize machine learning as a complementary method to infer Acrs in the candidate region. This approach is based on the premise that self-targeting events are successful cases of phage immune evasion, and that Acrs are most likely integrated by the bacteriophage and located in the prophage region (<xref rid="B46" ref-type="bibr">46</xref>). The overall prediction framework is illustrated in Figure <xref rid="F1" ref-type="fig">1A</xref>.</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>Workflow and output example for Acr prediction and key molecular events annotation. (<bold>A</bold>) Schematic of workflow for key molecular events annotation. (<bold>B</bold>) Schematic of workflow for Acr prediction. (<bold>C</bold>) The summarized table for key molecular events annotation. Circle plot for key molecular events (center panel), Acr prediction (top right panel), prophage event (top left panel), self-targeting event (bottom right panel), Interactive panels for CRISPR-Cas loci (bottom left panel). (<bold>D</bold>) Interactive panels for interacting MGE event.</p>
        </caption>
        <graphic xlink:href="gkad425fig1" position="float"/>
      </fig>
      <p>Figure <xref rid="F1" ref-type="fig">1C</xref> shows the results of the Acr prediction module with an example query on <italic toggle="yes">Staphylococcus schleiferi</italic> strain 5909-02. The webpage displays a download option and a summary table of the results at the top, listing the putative Acr(s), CRISPR-loci, ST event(s), and prophage region(s) closely associated with the Acr(s). A circle plot at the center of the page provides an intuitive visualization of the putative Acr(s) and three related molecular events, with more detailed information available by clicking on (Figure <xref rid="F1" ref-type="fig">1C</xref>, center panel). Four interactive panels provide sequential descriptions of the details of Acrs, CRISPR-Cas loci, self-targets, and prophages. The Acr prediction panel lists all putative candidates one by one, with a summary table providing comprehensive information at three levels: the protein itself, its neighbouring proteins, and the whole genome. Five proteins located upstream and downstream of the candidate protein are displayed in a linear protein plot, and detailed information can be accessed by clicking on (Figure <xref rid="F1" ref-type="fig">1C</xref>, top right panel). The prophage detection panel displays a table with detailed information about the prophage(s) in the genome (Figure <xref rid="F1" ref-type="fig">1C</xref>, top left panel). The ST detection panel displays a table summarizing the matches between the CRISPR spacer and the self-genome (Figure <xref rid="F1" ref-type="fig">1C</xref>, bottom right panel). The CRISPR-Cas locus panel is similar to the Acr prediction panel, with a summarized table and an interactive linear protein plot (Figure <xref rid="F1" ref-type="fig">1C</xref>, bottom left panel).</p>
    </sec>
    <sec id="SEC3-2">
      <title>Identification of novel class 2 CRISPR-cas loci</title>
      <p>Numerous orphan CRISPR systems exist in the genome without any homologs of published CRISPR effector proteins or accessory proteins. Therefore, the proteins surrounding these orphan CRISPR arrays may be potential novel CRISPR effector proteins. To identify these potential novel CRISPR effector proteins, we first explore orphan CRISPR arrays and investigate the proteins surrounding these arrays. We then screen neighboring proteins based on protein size and functional domain. Proteins with transposase annotation, containing nuclease function, or cleavage active domains such as RuvC, HNH, and HEPN domains, are given higher confidence as CRISPR effectors. As efficient CRISPR-Cas systems are generally preserved through evolution through independent evolution or horizontal gene transfer, and exist across diverse organisms, we search for homologs of candidate effector proteins and detect the corresponding CRISPR-Cas systems in their vicinity. Homologs of proteins and repeats that coexist across species would enhance the confidence in choosing the candidate systems. Finally, we construct a phylogenetic tree based on the resulting alignments of the predicted and known CRISPR-Cas effector protein sequences to gain insights into the origin of the novel systems and their evolutionary relationships with other known CRISPR-Cas systems. The overall prediction framework is illustrated in Figure <xref rid="F2" ref-type="fig">2A</xref>.</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>Workflow and output example for novel class 2 CRISPR-Cas loci identification. (<bold>A</bold>) Schematic of the pipeline for novel class 2 CRISPR-Cas loci identification. (<bold>B</bold>) The summarized table for novel class 2 CRISPR-Cas loci. (<bold>C–E</bold>) Interactive panels for detailed information of novel class 2 CRISPR-Cas loci. (<bold>F</bold>) Phylogenetic tree between candidates and previously known Class 2 effectors.</p>
        </caption>
        <graphic xlink:href="gkad425fig2" position="float"/>
      </fig>
      <p>Figure <xref rid="F2" ref-type="fig">2B</xref>-<xref rid="F2" ref-type="fig">F</xref> showcases the results of the identification of the novel class 2 CRISPR-Cas loci module with an example query of <italic toggle="yes">Armatimonadetes bacterium</italic> isolate ATM2 J3, a summary table reporting the novel CRISPR-Cas loci is displayed at the top of the webpage (Figure <xref rid="F2" ref-type="fig">2B</xref>). Interactive panels provide sequential details on novel CRISPR-Cas loci and their homologs. All potential candidates are listed one by one, providing detailed information on effector proteins and neighboring proteins, spacers and repeats in the CRISPR array (Figure <xref rid="F2" ref-type="fig">2C</xref>–<xref rid="F2" ref-type="fig">E</xref>). Additionally, an evolutionary panel displays a maximum likelihood tree between the novel candidate(s) and known effectors of class 2 CRISPR-Cas loci, providing insights into their evolutionary relationships (Figure <xref rid="F2" ref-type="fig">2F</xref>).</p>
    </sec>
    <sec id="SEC3-3">
      <title>Dissecting key molecular events during the co-evolution of CRISPR and anti-CRISPR</title>
      <p>Bacteria have developed various defense mechanisms to protect against phage attacks, and phages have been evolving anti-defense strategies under selection pressure. The evolutionary relationship and mechanism of bacteria and phages remain not fully understood. Nevertheless, there are several key molecular events that can help us investigate the co-evolution between bacteria and phages.</p>
      <p>We first comprehensively detect the CRISPR arrays through integrative analysis using PILER-CR (<xref rid="B32" ref-type="bibr">32</xref>), CRT (<xref rid="B33" ref-type="bibr">33</xref>), CRISPRCasFinder (<xref rid="B34" ref-type="bibr">34</xref>) and CRISPRidentify (<xref rid="B35" ref-type="bibr">35</xref>), then annotate the type of CRISPR repeat and Cas genes based on the domain profiles, and finally classify the system based on the dominant type of the Cas effector proteins. Next, we examine the occurrence of self-targeting event, which may indicate CRISPR-based autoimmunity, by scanning the spacer on the self-genome. We consider a hit that allows for a maximum of two mismatches at most between the spacer and a portion of the endogenous genomic sequence as credible self-targeting events. To gain insight into invading prokaryotes, we also annotate the potential invading phages or plasmids by sequence alignment. Finally, we annotate the possible Acrs on the genome for the convenience of investigating phage immune escape. The overall prediction framework is illustrated in Figure <xref rid="F1" ref-type="fig">1B</xref>.</p>
      <p>An example output for the dissection of key molecular events module is illustrated in Figure <xref rid="F1" ref-type="fig">1C</xref>, D. The result panel is similar to that of the Acr prediction module. When the <italic toggle="yes">Staphylococcus schleiferi</italic> strain 5909-02 is used as a query, a panel providing the result of MGE-targeted detection is added compared to the Acr prediction module. This panel reveals hits between CRISPR spacers and custom MGE genome databases, furnishing information on potential phage or plasmid invaders (Figure <xref rid="F1" ref-type="fig">1D</xref>).</p>
    </sec>
    <sec id="SEC3-4">
      <title>Performance for Acr protein prediction</title>
      <p>We evaluated the performance of predicting Acrs by comparing CRISPRimmunity's Acr prediction module with that of PaCRISPR (<xref rid="B30" ref-type="bibr">30</xref>) and AcrFinder (<xref rid="B14" ref-type="bibr">14</xref>) on an independent dataset containing 99 experimentally validated Acrs and 676 non-Acrs (see Materials and Methods). The cut-off threshold of the PaCRISPR output was set to 0.5 (Table S1). As shown in Figure <xref rid="F3" ref-type="fig">3A</xref>, CRISPRimmunity outperformed the other predictors on this independent dataset based on the four general evaluation metrics, including accuracy, F1-score, precision, and recall. When predicting non-Acrs from phages and bacterial MGEs, all methods achieved high true negative prediction accuracy (Figure <xref rid="F3" ref-type="fig">3B</xref>). Specifically, CRISPRimmunity, PaCRISPR, and AcrFinder correctly predicted 217 209 and 217 non-Acrs out of 217 phage proteins, and 250 and 249 non-Acrs out of 250 bacterial proteins, respectively. In summary, CRISPRimmunity showed good performance in identifying Acrs from both bacteria and phage proteins, outperforming other predictors on an independent experimentally validated Acr dataset.</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>Performance of CRISPRimmunity for Acr prediction and novel class 2 CRISPR-Cas loci identification. (<bold>A</bold>) Performance of Acr prediction module on benchmark dataset by four metrics including, precision accuracy, F1-score and recall. (<bold>B</bold>) True negative prediction accuracy for three Acr prediction algorithms. (<bold>C</bold>) Composition of novel class 2 CRISPR-Cas candidates from <italic toggle="yes">Armatimonadetes bacterium</italic>. (<bold>D</bold>) Cleavage active site of RuvC domain in the candidates. (<bold>E</bold>) Predicted recognized PAM for candidates. (<bold>F</bold>) Phylogenetic tree between type V candidates and previously known Class 2 effectors.</p>
        </caption>
        <graphic xlink:href="gkad425fig3" position="float"/>
      </fig>
    </sec>
    <sec id="SEC3-5">
      <title>Performance for identifying of novel class 2 CRISPR-cas effector</title>
      <p>To assess the performance for identifying novel class 2 CRISPR-Cas effectors, we used our module in CRISPRimmunity to detect the CRISPR-Cas loci in the 307 410 strains downloaded from NCBI in 2020. As a result, a candidate from <italic toggle="yes">Armatimonadetes bacterium</italic> species was identified, featuring a complete CRISPR array, a hypothetical protein as a possible effector protein, and three CRISPR auxiliary proteins Cas1, Cas2 and Cas4. Homology search further revealed other homologous candidate systems, and the candidate effectors were named AbCasN1 and AbCasN2 (Figure <xref rid="F3" ref-type="fig">3C</xref>). The sizes of AbCasN1 and AbCasN2 are 867 aa and 857 aa, respectively, and their sequence similarity is 0.44. The similarity of the CRISPR array is 0.76, while that of the auxiliary proteins (Cas1, Cas2, Cas4) is 0.58, 0.61 and 0.47, respectively (Figure <xref rid="F3" ref-type="fig">3C</xref>). The C-terminus of AbCasN1 and AbCasN2 displays the RuvC domain with three active sites (D, E and D) (Figure <xref rid="F3" ref-type="fig">3D</xref>). The possible sequence of PAM was predicted by CRISPRTarget (<xref rid="B47" ref-type="bibr">47</xref>) (Figure <xref rid="F3" ref-type="fig">3E</xref>), and the maximum-likelihood tree was constructed based on the resulting multiple alignment of the full-length proteins between the two candidate effectors and other known Class 2 effectors. The candidate effectors formed a separate branch, relatively closely related to Cas12j (Figure <xref rid="F3" ref-type="fig">3F</xref>). Significantly, this predicted effector protein was independently discovered and experimentally validated in another study, where the structure was resolved, and the gene editing activity in <italic toggle="yes">vitro</italic> and in <italic toggle="yes">vivo</italic> and the mechanism of action were elucidated (<xref rid="B48" ref-type="bibr">48</xref>). These results demonstrate the power of CRISPRimmunity in identifying novel class 2 CRISPR-Cas effectors.</p>
    </sec>
    <sec id="SEC3-6">
      <title>Case study 1: identification of a G-PAM SpyCas9 from genomic data</title>
      <p>Several CRISPR-Cas9 homologs have been utilized for genome editing, and Cas9’s recognition of DNA requires a specific sequence downstream of the target sequence, known as the prototypical spacer adjacent motif (PAM) (<xref rid="B49" ref-type="bibr">49</xref>). The smallest Cas9 orthology characterized to date for efficient <italic toggle="yes">in vivo</italic> genome editing is derived from <italic toggle="yes">Campylobacter jejuni</italic> species named CjCas9, comprising of 984 amino acid residues and 5′-NNNVRYM-3′ PAM (<xref rid="B50" ref-type="bibr">50</xref>).</p>
      <p>Cas9s with simple PAM requirements can facilitate extensive genome editing by editing a broader range of loci (<xref rid="B51" ref-type="bibr">51</xref>), so we attempted to identify CjCas9 with a simpler PAM. We used CRISPRimmunity to annotate the CRISPR-Cas systems on 16 723 strains of <italic toggle="yes">C. jejuni</italic> collected from NCBI. A CRISPR-Cas system with over three spacers and the distance between Cas proteins or CRISPR array less than 500-nt was assigned high confidence, and a total of 10 462 high-confidence type II CRISPR-Cas systems were identified. We then searched for natural variations in the PAM-interacting domain (PID) of Cas9s to identify orthologues of CjCas9. All CjCas9s were compared to the reference CjCas9 protein sequence from <italic toggle="yes">Campylobacter jejuni</italic> NCTC 11168 strain. Finally, a CjCas9 from <italic toggle="yes">C. jejuni</italic> NCTC 11951 strain (hereafter referred to as Cj2Cas9) was selected based on the only amino acid mutation in the PID compared with the reference CjCas9 protein sequence (Figure <xref rid="F4" ref-type="fig">4A</xref>, <xref rid="F4" ref-type="fig">B</xref>). To test the PAM of candidate Cj2Cas9, we constructed a plasmid library containing seven randomized DNA nucleotides next to the downstream of the 20-nt target sequence. We then transformed the expression plasmids of Cj2Cas9 into <italic toggle="yes">E. coli</italic>, purified ribonucleoprotein (RNP) complexes to cleave the constructed plasmid library <italic toggle="yes">in vitro</italic>, followed by high-throughput sequencing. Analysis of the sequencing data showed that Cj2Cas9 cleaved dsDNAs with a PAM sequence of 3'-G (Figure <xref rid="F4" ref-type="fig">4C</xref>). The purified Cj2Cas9 was determined by endonuclease digestion to validate its activity <italic toggle="yes">in vitro</italic>. As shown in Figure <xref rid="F4" ref-type="fig">4D</xref>, Cj2Cas9 successfully cleaved the plasmid with a PAM sequence of 3'-G. Finally, we conducted a double-strand DNA with a PAM sequence of 3'-G endonuclease digestion experiment using Cj2Cas9 and different sgRNA of various Cas9. We confirmed the specific double-strand DNA cleavage of Cj2Cas9 with its sgRNA (Figure <xref rid="F4" ref-type="fig">4E</xref>). In summary, CRISPRimmunity enabled us to identify a Cas9 homolog displaying G-PAM specificity for gene editing.</p>
      <fig position="float" id="F4">
        <label>Figure 4.</label>
        <caption>
          <p>Experimental validation of Cj2Cas9. (<bold>A</bold>) CRISPR-Cas locus of Cj2Cas9. (<bold>B</bold>) Sequence alignment between Cj2Cas9 and reference CjCas9. (<bold>C</bold>) High-throughput sequencing analysis of PAM sequences recognized by Cj2Cas9. (<bold>D</bold>) Plasmid cleavage experiment for Cj2Cas9. (<bold>E</bold>) Double-stranded DNA cleavage experiment for Cj2Cas9.</p>
        </caption>
        <graphic xlink:href="gkad425fig4" position="float"/>
      </fig>
    </sec>
    <sec id="SEC3-7">
      <title>Case study 2: identification of two compact Cas13ds from human gut microbiome</title>
      <p>The CRISPR/Cas13 system extends the application of CRISPR technology through RNA-targeted endonuclease-mediated degradation of RNA (<xref rid="B52" ref-type="bibr">52</xref>). Six subtypes (Cas13a, Cas13b, Cas13c, Cas13d, Cas13X and Cas13Y) have been identified in the Cas13 family, all of which are smaller than Cas9, and Cas13X is the smallest with 775 aa (<xref rid="B23" ref-type="bibr">23</xref>). As the is the largest micro-ecosystem in the human body, and the gut microbiome affects health in different ways. We used CRISPRimmunity to analyze the CRISPR composition of 208 209 human gut microbes obtained from MGnify (<xref rid="B53" ref-type="bibr">53</xref>) and identified two compact Cas13d candidates (hereafter referred to as cCas13d1 and cCas13d2). The CRISPR loci contain a compact Cas13d gene, a CRISPR array with 5 spacers, and the presence or absence of Cas1 and Cas2 (Figure <xref rid="F5" ref-type="fig">5A</xref>). The HEPN ribonuclease domain of the protein features two RxxxxH motifs separately located at the N and C terminal of the protein (Figure <xref rid="F5" ref-type="fig">5B</xref>), with a 30-nt spacer flanked by two 36-nt direct repeat (DR) sequences (Figure <xref rid="F5" ref-type="fig">5C</xref>). The protein sizes of cCas13d1 and cCas13d2 are 871 aa and 721 aa respectively, smaller than any previously known Cas13d effectors (∼930 aa) (<xref rid="B54" ref-type="bibr">54</xref>). To gain insights into the origin and evolution of cCas13ds, we constructed a maximum-likelihood tree on the resulting multiple alignments of the full-length proteins between cCas13ds and previously published Cas13 effectors. The cCas13ds family is closely related to the previously known Cas13ds (Figure <xref rid="F5" ref-type="fig">5D</xref>). In addition, 15 out of 69 type V CRISPR effector candidates identified have been validated to have <italic toggle="yes">in vitro</italic> cleavage activities (Figure S2, Table S3). In summary, CRISPRimmunity have the potential to advance genomic engineering and RNA editing technologies by providing accurate identification for novel CRISPR-Cas systems.</p>
      <fig position="float" id="F5">
        <label>Figure 5.</label>
        <caption>
          <p>Characterization of small Cas13d candidates. (<bold>A</bold>) CRISPR-Cas loci of small Cas13d candidates. (<bold>B</bold>) Cleavage active site of HEPN domain in small Cas13d candidates. (<bold>C</bold>) Predicted secondary structure for repeat jointly spacer. (<bold>D</bold>) The maximum-likelihood tree of small Cas13d candidates and other known Cas13 family effectors.</p>
        </caption>
        <graphic xlink:href="gkad425fig5" position="float"/>
      </fig>
    </sec>
    <sec id="SEC3-8">
      <title>Case study 3: annotation of Acrs and key molecular events in 235 microbial strains</title>
      <p>Anti-CRISPRdb (<xref rid="B13" ref-type="bibr">13</xref>) has manually collected published Acrs through literature searches. However, A more comprehensive analysis of the strains containing Acrs can improve our understanding of the co-evolution between bacteria and phages. Therefore, we downloaded 235 microbial genomes containing 99 known Acrs from anti-CRISPRdb for systematic analysis, including the annotation of potential Acrs, class 2 CRISPR-Cas effector proteins, and various key molecular events, as displayed on the ‘CASE STUDY’ panel of the website (Figure <xref rid="F6" ref-type="fig">6A</xref>). In addition to the 99 Acrs known to inhibit CRISPR activity validated by experiments, we also predicted 297 homologs to known Acrs and 197 novel Acrs, as shown in Figure <xref rid="F6" ref-type="fig">6B</xref>. In 42% of the analyzed microbial genomes, only one or one type of Acr was detectable (Figure <xref rid="F6" ref-type="fig">6C</xref>), but in some species, such as <italic toggle="yes">Pseudomonas aeruginosa</italic> and <italic toggle="yes">Moraxella bovoculi</italic>, multiple or multiple types of Acrs were detected simultaneously, indicating a fierce CRISPR and anti-CRISPR arms race in these organisms (Figure <xref rid="F6" ref-type="fig">6D</xref>). Among the microbial genomes containing Acrs, 26% detected self-targeting events, 64% detected interacting phages, and 71% Acrs were located in prophages, as shown in Table S2. In summary, we can conduct further analyses of interest based on the detailed result of CRISPRimmunity, deepening understanding of the co-evolutionary mechanisms of CRISPR and anti-CRISPR systems.</p>
      <fig position="float" id="F6">
        <label>Figure 6.</label>
        <caption>
          <p>Dissection of key molecular events in 235 Acr-containing microbial strains. (<bold>A</bold>) Overview of the result for annotation of key molecular events in 235 Acr-containing microbial strains. (<bold>B</bold>) Predicted Acr homologs and novel Acrs in 235 Acr-containing microbial strains. (<bold>C</bold>) Distribution of copy number of Acrs per strain. (<bold>D</bold>) Detailed information of strains consisting multiple Acrs.</p>
        </caption>
        <graphic xlink:href="gkad425fig6" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="discussion" id="SEC4">
    <title>DISCUSSION</title>
    <p>This study introduces CRISPRimmunity, an advanced and user-friendly platform designed for comprehensive CRISPR-oriented analysis. This platform goes beyond existing CRISPR-Cas associated tools by providing a more integrative and evolutionary perspective on the CRISPR-Cas and anti-CRISPR systems. CRISPRimmunity develops streamlined amalgamate analysis to establish the annotation of crucial molecular events, the prediction of Acrs, identification new class 2 CRISPR-Cas loci, and linking bacteria and phages based on CRISPR signals.</p>
    <p>CRISPRimmunity offers a variety of functionalities, including diverse methods for detecting CRISPR arrays, a series of custom CRISPR-oriented databases for annotating known Acrs and Acas, type 2 CRISPR-Cas systems, repeats of classified CRISPR systems, HTH domains, and mobile genetic elements. The platform also provides multiple approaches for predicting Acrs, such as guilt-by-association analysis and combined analysis of prophage and self-targeting. When tested on experimentally validated Acrs and benchmark datasets of non-Acrs, CRISPRimmunity outperforms other existing Acrs prediction tools. Furthermore, CRISPRimmunity introduces a novel class 2 CRISPR-Cas loci detection pipeline. Several class 2 effector candidates identified (15/69) have been validated to have <italic toggle="yes">in vitro</italic> cleavage activities (Figure <xref rid="F4" ref-type="fig">4</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure S2</xref>, <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S3</xref>). In addition to its advanced functionalities, CRISPRimmunity also provides various visualizations, customization options, and detailed information to facilitate future experimental design, as well as exportable results in machine-readable format for further analysis. Its well-designed graphical user interface and detailed tutorials make it accessible to users with different levels of expertise. Moreover, CRISPRimmunity provides a ‘BROWSE’ option that allows CRISPR engineers or experimentalists to browse and query pre-identified CRISPR-related events on NCBI’s 18 408 completely sequenced bacterial strains and 235 Acr-containing bacterial strains. The ‘DOWNLOAD’ option offers download of the annotated CRISPR-related results from NCBI’s bacterial strains and human gut microbiome, as well as a suite of CRISPR-oriented databases for further data mining. A stand-alone version of CRISPRimmunity is also available on GitHub at <ext-link xlink:href="https://github.com/HIT-ImmunologyLab/CRISPRimmunity" ext-link-type="uri">https://github.com/HIT-ImmunologyLab/CRISPRimmunity</ext-link> to facilitate batch analysis.</p>
    <p>The adaptive immunity of prokaryotes has undergone a lengthy evolutionary process. The transposon-associated IS200/IS605 IscB and TnpB molecules are the ancestors of type II and V CRISPR-Cas effectors (<xref rid="B55" ref-type="bibr">55</xref>,<xref rid="B56" ref-type="bibr">56</xref>). Recent studies have revealed that IscB and TnpB molecules are RNA-guided DNA endonucleases (<xref rid="B57" ref-type="bibr">57</xref>,<xref rid="B58" ref-type="bibr">58</xref>), expanding our knowledge of the adaptive immunity of prokaryotes. Our future goal is to incorporate more types of defense and anti-defense-related information into CRISPRimmunity, providing additional biological insights and enhancing our understanding of the adaptive immunity in prokaryotes. We hope that CRISPRimmunity will facilitate research into the mechanisms of the CRISPR-Cas and Acr systems from a co-evolutionary perspective. Ultimately, leading to the discover of more efficient and less off-target genome editing tools.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC5">
    <title>DATA AVAILABILITY</title>
    <p>The CRISPRimmunity is an open-access resource and is publicly available at <ext-link xlink:href="http://www.microbiome-bigdata.com/CRISPRimmunity/index/home" ext-link-type="uri">http://www.microbiome-bigdata.com/CRISPRimmunity</ext-link>. The application is free and open to all users with no login requirement. The source code of CRISPRimmunity is published on GitHub via <ext-link xlink:href="https://github.com/HIT-ImmunologyLab/CRISPRimmunity" ext-link-type="uri">https://github.com/HIT-ImmunologyLab/CRISPRimmunity</ext-link>.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkad425_Supplemental_Files</label>
      <media xlink:href="gkad425_supplemental_files.zip">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ACK1">
    <title>ACKNOWLEDGEMENTS</title>
    <p>We sincerely thank all the students and staff for their assistance in this work. We also want to thank Nucleic Acids Research editorial and support teams for their help and advice.</p>
  </ack>
  <sec id="SEC6">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkad425#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC7">
    <title>FUNDING</title>
    <p>National Natural Science Foundation of China (NSFC) [61872117, 31825008, 31422014]; Tencent Foundation through the XPLORER PRIZE and the New Cornerstone Science Foundation (to Z.H.); Heilongjiang Touyan Team (HITTY-20190034 to Z.H.). Funding for open access charge: National Natural Science Foundation of China (NSFC) [61872117, 31825008, 31422014]; Tencent Foundation through the XPLORER PRIZE and the New Cornerstone Science Foundation (to Z.H.); Heilongjiang Touyan Team [HITTY-20190034 to Z.H.].</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>J.Y.</given-names></string-name>, <string-name><surname>Doudna</surname><given-names>J.A.</given-names></string-name></person-group><article-title>CRISPR technology: A decade of genome editing is onlythe beginning</article-title>. <source>Science</source>. <year>2023</year>; <volume>379</volume>:<fpage>eadd8643</fpage>.<pub-id pub-id-type="pmid">36656942</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gootenberg</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Abudayyeh</surname><given-names>O.O.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>J.W.</given-names></string-name>, <string-name><surname>Essletzbichler</surname><given-names>P.</given-names></string-name>, <string-name><surname>Dy</surname><given-names>A.J.</given-names></string-name>, <string-name><surname>Joung</surname><given-names>J.</given-names></string-name>, <string-name><surname>Verdine</surname><given-names>V.</given-names></string-name>, <string-name><surname>Donghia</surname><given-names>N.</given-names></string-name>, <string-name><surname>Daringer</surname><given-names>N.M.</given-names></string-name>, <string-name><surname>Freije</surname><given-names>C.A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Nucleic acid detection with CRISPR-Cas13a/C2c2</article-title>. <source>Science</source>. <year>2017</year>; <volume>356</volume>:<fpage>438</fpage>–<lpage>442</lpage>.<pub-id pub-id-type="pmid">28408723</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kellner</surname><given-names>M.J.</given-names></string-name>, <string-name><surname>Koob</surname><given-names>J.G.</given-names></string-name>, <string-name><surname>Gootenberg</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Abudayyeh</surname><given-names>O.O.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>F.</given-names></string-name></person-group><article-title>SHERLOCK: nucleic acid detection with CRISPR nucleases</article-title>. <source>Nat. Protoc.</source><year>2019</year>; <volume>14</volume>:<fpage>2986</fpage>–<lpage>3012</lpage>.<pub-id pub-id-type="pmid">31548639</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhou</surname><given-names>F.</given-names></string-name>, <string-name><surname>Gan</surname><given-names>R.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Ren</surname><given-names>C.</given-names></string-name>, <string-name><surname>Yu</surname><given-names>L.</given-names></string-name>, <string-name><surname>Si</surname><given-names>Y.</given-names></string-name></person-group><article-title>PHISDetector: A tool to detect diverse In silico phage-host interaction signals for virome studies</article-title>. <source>Genomics Proteomics Bioinformatics</source>. <year>2022</year>; <volume>20</volume>:<fpage>508</fpage>–<lpage>523</lpage>.<pub-id pub-id-type="pmid">35272051</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kwon</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ra</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>S.</given-names></string-name>, <string-name><surname>Baek</surname><given-names>I.J.</given-names></string-name>, <string-name><surname>Khim</surname><given-names>K.W.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>E.A.</given-names></string-name>, <string-name><surname>Song</surname><given-names>E.K.</given-names></string-name>, <string-name><surname>Otarbayev</surname><given-names>D.</given-names></string-name>, <string-name><surname>Jung</surname><given-names>W.</given-names></string-name>, <string-name><surname>Park</surname><given-names>Y.H.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Precision targeting tumor cells using cancer-specific InDel mutations with CRISPR-Cas9</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2022</year>; <volume>119</volume>:<fpage>e2103532119</fpage>.<pub-id pub-id-type="pmid">35217600</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jiang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Mei</surname><given-names>M.</given-names></string-name>, <string-name><surname>Li</surname><given-names>B.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zu</surname><given-names>W.</given-names></string-name>, <string-name><surname>Tian</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Dong</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Tan</surname><given-names>X.</given-names></string-name></person-group><article-title>A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo</article-title>. <source>Cell Res.</source><year>2017</year>; <volume>27</volume>:<fpage>440</fpage>–<lpage>443</lpage>.<pub-id pub-id-type="pmid">28117345</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koonin</surname><given-names>E.V.</given-names></string-name>, <string-name><surname>Makarova</surname><given-names>K.S.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>F.</given-names></string-name></person-group><article-title>2017) Diversity, classification and evolution of CRISPR-Cas systems</article-title>. <source>Curr. Opin. Microbiol.</source><volume>37</volume>:<fpage>67</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="pmid">28605718</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z.</given-names></string-name></person-group><article-title>Mechanistic insights into the versatile class II CRISPR toolbox</article-title>. <source>Trends Biochem. Sci.</source><year>2022</year>; <volume>47</volume>:<fpage>433</fpage>–<lpage>450</lpage>.<pub-id pub-id-type="pmid">34920928</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>X.H.</given-names></string-name>, <string-name><surname>Tee</surname><given-names>L.Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X.G.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Q.S.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>S.H.</given-names></string-name></person-group><article-title>Off-target Effects in CRISPR/Cas9-mediated Genome Engineering</article-title>. <source>Mol. Ther Nucleic Acids</source>. <year>2015</year>; <volume>4</volume>:<fpage>e264</fpage>.<pub-id pub-id-type="pmid">26575098</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pawluk</surname><given-names>A.</given-names></string-name>, <string-name><surname>Davidson</surname><given-names>A.R.</given-names></string-name>, <string-name><surname>Maxwell</surname><given-names>K.L.</given-names></string-name></person-group><article-title>Anti-CRISPR: discovery, mechanism and function</article-title>. <source>Nat. Rev. Microbiol.</source><year>2018</year>; <volume>16</volume>:<fpage>12</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">29062071</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhuo</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>J.H.</given-names></string-name>, <string-name><surname>Jiao</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>D.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>L.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>H.W.</given-names></string-name>, <string-name><surname>Tao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>M.</given-names></string-name></person-group><article-title>Spatiotemporal control of CRISPR/Cas9 gene editing</article-title>. <source>Signal Transduct. Target. Ther.</source><year>2021</year>; <volume>6</volume>:<fpage>238</fpage>.<pub-id pub-id-type="pmid">34148061</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cheng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Meng</surname><given-names>X.</given-names></string-name>, <string-name><surname>You</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name></person-group><article-title>A CRISPR evolutionary arms race: structural insights into viral anti-CRISPR/Cas responses</article-title>. <source>Cell Res.</source><year>2016</year>; <volume>26</volume>:<fpage>1165</fpage>–<lpage>1168</lpage>.<pub-id pub-id-type="pmid">27585537</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dong</surname><given-names>C.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Ma</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zeng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Pu</surname><given-names>D.K.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>C.S.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>F.B.</given-names></string-name></person-group><article-title>Anti-CRISPRdb v2.2: an online repository of anti-CRISPR proteins including information on inhibitory mechanisms, activities and neighbors of curated anti-CRISPR proteins</article-title>. <source>Database (Oxford)</source>. <year>2022</year>; <volume>2022</volume>:<fpage>baac010</fpage>.<pub-id pub-id-type="pmid">35348649</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Gomez</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>Y.</given-names></string-name></person-group><article-title>AcrFinder: genome mining anti-CRISPR operons in prokaryotes and their viruses</article-title>. <source>Nucleic Acids Res</source>. <year>2020</year>; <volume>48</volume>:<fpage>W358</fpage>–<lpage>W365</lpage>.<pub-id pub-id-type="pmid">32402073</pub-id></mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Huang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Yi</surname><given-names>H.</given-names></string-name>, <string-name><surname>Asif</surname><given-names>A.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lithgow</surname><given-names>T.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Minhas</surname><given-names>F.</given-names></string-name>, <string-name><surname>Yin</surname><given-names>Y.</given-names></string-name></person-group><article-title>AcrDB: a database of anti-CRISPR operons in prokaryotes and viruses</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D622</fpage>–<lpage>d629</lpage>.<pub-id pub-id-type="pmid">33068435</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Buchfink</surname><given-names>B.</given-names></string-name>, <string-name><surname>Reuter</surname><given-names>K.</given-names></string-name>, <string-name><surname>Drost</surname><given-names>H.G.</given-names></string-name></person-group><article-title>Sensitive protein alignments at tree-of-life scale using DIAMOND</article-title>. <source>Nat. Methods</source>. <year>2021</year>; <volume>18</volume>:<fpage>366</fpage>–<lpage>368</lpage>.<pub-id pub-id-type="pmid">33828273</pub-id></mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marchler-Bauer</surname><given-names>A.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Anderson</surname><given-names>J.B.</given-names></string-name>, <string-name><surname>Chitsaz</surname><given-names>F.</given-names></string-name>, <string-name><surname>Derbyshire</surname><given-names>M.K.</given-names></string-name>, <string-name><surname>DeWeese-Scott</surname><given-names>C.</given-names></string-name>, <string-name><surname>Fong</surname><given-names>J.H.</given-names></string-name>, <string-name><surname>Geer</surname><given-names>L.Y.</given-names></string-name>, <string-name><surname>Geer</surname><given-names>R.C.</given-names></string-name>, <string-name><surname>Gonzales</surname><given-names>N.R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>CDD: a Conserved Domain Database for the functional annotation of proteins</article-title>. <source>Nucleic Acids Res.</source><year>2011</year>; <volume>39</volume>:<fpage>D225</fpage>–<lpage>D229</lpage>.<pub-id pub-id-type="pmid">21109532</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Marchler-Bauer</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bryant</surname><given-names>S.H.</given-names></string-name></person-group><article-title>CD-Search: protein domain annotations on the fly</article-title>. <source>Nucleic Acids Res</source>. <year>2004</year>; <volume>32</volume>:<fpage>W327</fpage>–<lpage>W331</lpage>.<pub-id pub-id-type="pmid">15215404</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>S.</given-names></string-name>, <string-name><surname>Ren</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>H.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>F.</given-names></string-name>, <string-name><surname>Jia</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>K.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z.</given-names></string-name></person-group><article-title>CRISPRminer is a knowledge base for exploring CRISPR-Cas systems in microbe and phage interactions</article-title>. <source>Commun. Biol.</source><year>2018</year>; <volume>1</volume>:<fpage>180</fpage>.<pub-id pub-id-type="pmid">30393777</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pourcel</surname><given-names>C.</given-names></string-name>, <string-name><surname>Touchon</surname><given-names>M.</given-names></string-name>, <string-name><surname>Villeriot</surname><given-names>N.</given-names></string-name>, <string-name><surname>Vernadet</surname><given-names>J.P.</given-names></string-name>, <string-name><surname>Couvin</surname><given-names>D.</given-names></string-name>, <string-name><surname>Toffano-Nioche</surname><given-names>C.</given-names></string-name>, <string-name><surname>Vergnaud</surname><given-names>G.</given-names></string-name></person-group><article-title>CRISPRCasdb a successor of CRISPRdb containing CRISPR arrays and cas genes from complete genome sequences, and tools to download and query lists of repeats and spacers</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D535</fpage>–<lpage>D544</lpage>.<pub-id pub-id-type="pmid">31624845</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>S.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>A.</given-names></string-name>, <string-name><surname>He</surname><given-names>B.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Chai</surname><given-names>G.</given-names></string-name>, <string-name><surname>Guo</surname><given-names>F.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>J.</given-names></string-name></person-group><article-title>CasPDB: an integrated and annotated database for Cas proteins from bacteria and archaea</article-title>. <source>Database (Oxford)</source>. <year>2019</year>; <volume>2019</volume>:<fpage>baac010</fpage>.</mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pausch</surname><given-names>P.</given-names></string-name>, <string-name><surname>Al-Shayeb</surname><given-names>B.</given-names></string-name>, <string-name><surname>Bisom-Rapp</surname><given-names>E.</given-names></string-name>, <string-name><surname>Tsuchida</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Cress</surname><given-names>B.F.</given-names></string-name>, <string-name><surname>Knott</surname><given-names>G.J.</given-names></string-name>, <string-name><surname>Jacobsen</surname><given-names>S.E.</given-names></string-name>, <string-name><surname>Banfield</surname><given-names>J.F.</given-names></string-name>, <string-name><surname>Doudna</surname><given-names>J.A.</given-names></string-name></person-group><article-title>CRISPR-CasΦ from huge phages is a hypercompact genome editor</article-title>. <source>Science</source>. <year>2020</year>; <volume>369</volume>:<fpage>333</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">32675376</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xu</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Xiao</surname><given-names>Q.</given-names></string-name>, <string-name><surname>He</surname><given-names>B.</given-names></string-name>, <string-name><surname>Geng</surname><given-names>G.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Cao</surname><given-names>B.</given-names></string-name>, <string-name><surname>Dong</surname><given-names>X.</given-names></string-name>, <string-name><surname>Bai</surname><given-names>W.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Programmable RNA editing with compact CRISPR-Cas13 systems from uncultivated microbes</article-title>. <source>Nat. Methods</source>. <year>2021</year>; <volume>18</volume>:<fpage>499</fpage>–<lpage>506</lpage>.<pub-id pub-id-type="pmid">33941935</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karvelis</surname><given-names>T.</given-names></string-name>, <string-name><surname>Bigelyte</surname><given-names>G.</given-names></string-name>, <string-name><surname>Young</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Hou</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zedaveinyte</surname><given-names>R.</given-names></string-name>, <string-name><surname>Budre</surname><given-names>K.</given-names></string-name>, <string-name><surname>Paulraj</surname><given-names>S.</given-names></string-name>, <string-name><surname>Djukanovic</surname><given-names>V.</given-names></string-name>, <string-name><surname>Gasior</surname><given-names>S.</given-names></string-name>, <string-name><surname>Silanskas</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>5016</fpage>–<lpage>5023</lpage>.<pub-id pub-id-type="pmid">32246713</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Potter</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Luciani</surname><given-names>A.</given-names></string-name>, <string-name><surname>Eddy</surname><given-names>S.R.</given-names></string-name>, <string-name><surname>Park</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Lopez</surname><given-names>R.</given-names></string-name>, <string-name><surname>Finn</surname><given-names>R.D.</given-names></string-name></person-group><article-title>HMMER web server: 2018 update</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>W200</fpage>–<lpage>W204</lpage>.<pub-id pub-id-type="pmid">29905871</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Watters</surname><given-names>K.E.</given-names></string-name>, <string-name><surname>Fellmann</surname><given-names>C.</given-names></string-name>, <string-name><surname>Bai</surname><given-names>H.B.</given-names></string-name>, <string-name><surname>Ren</surname><given-names>S.M.</given-names></string-name>, <string-name><surname>Doudna</surname><given-names>J.A.</given-names></string-name></person-group><article-title>Systematic discovery of natural CRISPR-Cas12a inhibitors</article-title>. <source>Science</source>. <year>2018</year>; <volume>362</volume>:<fpage>236</fpage>–<lpage>239</lpage>.<pub-id pub-id-type="pmid">30190307</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Benson</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Cavanaugh</surname><given-names>M.</given-names></string-name>, <string-name><surname>Clark</surname><given-names>K.</given-names></string-name>, <string-name><surname>Karsch-Mizrachi</surname><given-names>I.</given-names></string-name>, <string-name><surname>Lipman</surname><given-names>D.J.</given-names></string-name>, <string-name><surname>Ostell</surname><given-names>J.</given-names></string-name>, <string-name><surname>Sayers</surname><given-names>E.W.</given-names></string-name></person-group><article-title>GenBank</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>; <volume>45</volume>:<fpage>D37</fpage>–<lpage>D42</lpage>.<pub-id pub-id-type="pmid">27899564</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fu</surname><given-names>L.</given-names></string-name>, <string-name><surname>Niu</surname><given-names>B.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>W.</given-names></string-name></person-group><article-title>CD-HIT: accelerated for clustering the next-generation sequencing data</article-title>. <source>Bioinformatics</source>. <year>2012</year>; <volume>28</volume>:<fpage>3150</fpage>–<lpage>3152</lpage>.<pub-id pub-id-type="pmid">23060610</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Madden</surname><given-names>T.L.</given-names></string-name></person-group><article-title>PowerBLAST: a new network BLAST application for interactive or automated sequence analysis and annotation</article-title>. <source>Genome Res.</source><year>1997</year>; <volume>7</volume>:<fpage>649</fpage>–<lpage>656</lpage>.<pub-id pub-id-type="pmid">9199938</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Dai</surname><given-names>W.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Xie</surname><given-names>R.</given-names></string-name>, <string-name><surname>Dunstan</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Stubenrauch</surname><given-names>C.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Lithgow</surname><given-names>T.</given-names></string-name></person-group><article-title>PaCRISPR: a server for predicting and visualizing anti-CRISPR proteins</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>W348</fpage>–<lpage>W357</lpage>.<pub-id pub-id-type="pmid">32459325</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cock</surname><given-names>P.J.</given-names></string-name>, <string-name><surname>Antao</surname><given-names>T.</given-names></string-name>, <string-name><surname>Chang</surname><given-names>J.T.</given-names></string-name>, <string-name><surname>Chapman</surname><given-names>B.A.</given-names></string-name>, <string-name><surname>Cox</surname><given-names>C.J.</given-names></string-name>, <string-name><surname>Dalke</surname><given-names>A.</given-names></string-name>, <string-name><surname>Friedberg</surname><given-names>I.</given-names></string-name>, <string-name><surname>Hamelryck</surname><given-names>T.</given-names></string-name>, <string-name><surname>Kauff</surname><given-names>F.</given-names></string-name>, <string-name><surname>Wilczynski</surname><given-names>B.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Biopython: freely available Python tools for computational molecular biology and bioinformatics</article-title>. <source>Bioinformatics</source>. <year>2009</year>; <volume>25</volume>:<fpage>1422</fpage>–<lpage>1423</lpage>.<pub-id pub-id-type="pmid">19304878</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Edgar</surname><given-names>R.C.</given-names></string-name></person-group><article-title>PILER-CR: fast and accurate identification of CRISPR repeats</article-title>. <source>BMC Bioinformatics</source>. <year>2007</year>; <volume>8</volume>:<fpage>18</fpage>.<pub-id pub-id-type="pmid">17239253</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bland</surname><given-names>C.</given-names></string-name>, <string-name><surname>Ramsey</surname><given-names>T.L.</given-names></string-name>, <string-name><surname>Sabree</surname><given-names>F.</given-names></string-name>, <string-name><surname>Lowe</surname><given-names>M.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>K.</given-names></string-name>, <string-name><surname>Kyrpides</surname><given-names>N.C.</given-names></string-name>, <string-name><surname>Hugenholtz</surname><given-names>P.</given-names></string-name></person-group><article-title>CRISPR recognition tool (CRT): a tool for automatic detection of clustered regularly interspaced palindromic repeats</article-title>. <source>BMC Bioinformatics</source>. <year>2007</year>; <volume>8</volume>:<fpage>209</fpage>.<pub-id pub-id-type="pmid">17577412</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Couvin</surname><given-names>D.</given-names></string-name>, <string-name><surname>Bernheim</surname><given-names>A.</given-names></string-name>, <string-name><surname>Toffano-Nioche</surname><given-names>C.</given-names></string-name>, <string-name><surname>Touchon</surname><given-names>M.</given-names></string-name>, <string-name><surname>Michalik</surname><given-names>J.</given-names></string-name>, <string-name><surname>Néron</surname><given-names>B.</given-names></string-name>, <string-name><surname>Rocha</surname><given-names>E.P.C.</given-names></string-name>, <string-name><surname>Vergnaud</surname><given-names>G.</given-names></string-name>, <string-name><surname>Gautheret</surname><given-names>D.</given-names></string-name>, <string-name><surname>Pourcel</surname><given-names>C.</given-names></string-name></person-group><article-title>CRISPRCasFinder, an update of CRISRFinder, includes a portable version, enhanced performance and integrates search for Cas proteins</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>; <volume>46</volume>:<fpage>W246</fpage>–<lpage>W251</lpage>.<pub-id pub-id-type="pmid">29790974</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mitrofanov</surname><given-names>A.</given-names></string-name>, <string-name><surname>Alkhnbashi</surname><given-names>O.S.</given-names></string-name>, <string-name><surname>Shmakov</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Makarova</surname><given-names>K.S.</given-names></string-name>, <string-name><surname>Koonin</surname><given-names>E.V.</given-names></string-name>, <string-name><surname>Backofen</surname><given-names>R.</given-names></string-name></person-group><article-title>CRISPRidentify: identification of CRISPR arrays using machine learning approach</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>e20</fpage>.<pub-id pub-id-type="pmid">33290505</pub-id></mixed-citation>
    </ref>
    <ref id="B36">
      <label>36.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hyatt</surname><given-names>D.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>G.L.</given-names></string-name>, <string-name><surname>Locascio</surname><given-names>P.F.</given-names></string-name>, <string-name><surname>Land</surname><given-names>M.L.</given-names></string-name>, <string-name><surname>Larimer</surname><given-names>F.W.</given-names></string-name>, <string-name><surname>Hauser</surname><given-names>L.J.</given-names></string-name></person-group><article-title>Prodigal: prokaryotic gene recognition and translation initiation site identification</article-title>. <source>BMC Bioinformatics</source>. <year>2010</year>; <volume>11</volume>:<fpage>119</fpage>.<pub-id pub-id-type="pmid">20211023</pub-id></mixed-citation>
    </ref>
    <ref id="B37">
      <label>37.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Katoh</surname><given-names>K.</given-names></string-name>, <string-name><surname>Standley</surname><given-names>D.M.</given-names></string-name></person-group><article-title>MAFFT multiple sequence alignment software version 7: improvements in performance and usability</article-title>. <source>Mol. Biol. Evol.</source><year>2013</year>; <volume>30</volume>:<fpage>772</fpage>–<lpage>780</lpage>.<pub-id pub-id-type="pmid">23329690</pub-id></mixed-citation>
    </ref>
    <ref id="B38">
      <label>38.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gan</surname><given-names>R.</given-names></string-name>, <string-name><surname>Zhou</surname><given-names>F.</given-names></string-name>, <string-name><surname>Si</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>C.</given-names></string-name>, <string-name><surname>Ren</surname><given-names>C.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>F.</given-names></string-name></person-group><article-title>2022) DBSCAN-SWA: an Integrated Tool for Rapid Prophage Detection and Annotation</article-title>. <source>Front. Genet.</source><volume>13</volume>:<fpage>885048</fpage>.<pub-id pub-id-type="pmid">35518360</pub-id></mixed-citation>
    </ref>
    <ref id="B39">
      <label>39.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eitzinger</surname><given-names>S.</given-names></string-name>, <string-name><surname>Asif</surname><given-names>A.</given-names></string-name>, <string-name><surname>Watters</surname><given-names>K.E.</given-names></string-name>, <string-name><surname>Iavarone</surname><given-names>A.T.</given-names></string-name>, <string-name><surname>Knott</surname><given-names>G.J.</given-names></string-name>, <string-name><surname>Doudna</surname><given-names>J.A.</given-names></string-name>, <string-name><surname>Minhas</surname><given-names>F.</given-names></string-name></person-group><article-title>2020) Machine learning predicts new anti-CRISPR proteins</article-title>. <source>Nucleic Acids Res.</source><volume>48</volume>:<fpage>4698</fpage>–<lpage>4708</lpage>.<pub-id pub-id-type="pmid">32286628</pub-id></mixed-citation>
    </ref>
    <ref id="B40">
      <label>40.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Price</surname><given-names>M.N.</given-names></string-name>, <string-name><surname>Dehal</surname><given-names>P.S.</given-names></string-name>, <string-name><surname>Arkin</surname><given-names>A.P.</given-names></string-name></person-group><article-title>FastTree 2–approximately maximum-likelihood trees for large alignments</article-title>. <source>PLoS One</source>. <year>2010</year>; <volume>5</volume>:<fpage>e9490</fpage>.<pub-id pub-id-type="pmid">20224823</pub-id></mixed-citation>
    </ref>
    <ref id="B41">
      <label>41.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yu</surname><given-names>G.</given-names></string-name></person-group><article-title>Using ggtree to visualize data on tree-like structures</article-title>. <source>Curr. Protoc. Bioinformatics</source>. <year>2020</year>; <volume>69</volume>:<fpage>e96</fpage>.<pub-id pub-id-type="pmid">32162851</pub-id></mixed-citation>
    </ref>
    <ref id="B42">
      <label>42.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guo</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ren</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Tang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>B.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z.</given-names></string-name></person-group><article-title>Structural insights into a high fidelity variant of SpCas9</article-title>. <source>Cell Res.</source><year>2019</year>; <volume>29</volume>:<fpage>183</fpage>–<lpage>192</lpage>.<pub-id pub-id-type="pmid">30664728</pub-id></mixed-citation>
    </ref>
    <ref id="B43">
      <label>43.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karvelis</surname><given-names>T.</given-names></string-name>, <string-name><surname>Gasiunas</surname><given-names>G.</given-names></string-name>, <string-name><surname>Young</surname><given-names>J.</given-names></string-name>, <string-name><surname>Bigelyte</surname><given-names>G.</given-names></string-name>, <string-name><surname>Silanskas</surname><given-names>A.</given-names></string-name>, <string-name><surname>Cigan</surname><given-names>M.</given-names></string-name>, <string-name><surname>Siksnys</surname><given-names>V.</given-names></string-name></person-group><article-title>Rapid characterization of CRISPR-Cas9 protospacer adjacent motif sequence elements</article-title>. <source>Genome Biol.</source><year>2015</year>; <volume>16</volume>:<fpage>253</fpage>.<pub-id pub-id-type="pmid">26585795</pub-id></mixed-citation>
    </ref>
    <ref id="B44">
      <label>44.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>C.</given-names></string-name>, <string-name><surname>Jiao</surname><given-names>X.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Song</surname><given-names>L.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Gao</surname><given-names>C.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>K.</given-names></string-name></person-group><article-title>Hi-TOM: a platform for high-throughput tracking of mutations induced by CRISPR/Cas systems</article-title>. <source>Sci. China Life Sci.</source><year>2019</year>; <volume>62</volume>:<fpage>1</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">30446870</pub-id></mixed-citation>
    </ref>
    <ref id="B45">
      <label>45.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maxwell</surname><given-names>K.L.</given-names></string-name></person-group><article-title>The Anti-CRISPR Story: a Battle for Survival</article-title>. <source>Mol Cell</source>. <year>2017</year>; <volume>68</volume>:<fpage>8</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="pmid">28985512</pub-id></mixed-citation>
    </ref>
    <ref id="B46">
      <label>46.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dedrick</surname><given-names>R.M.</given-names></string-name>, <string-name><surname>Jacobs-Sera</surname><given-names>D.</given-names></string-name>, <string-name><surname>Bustamante</surname><given-names>C.A.</given-names></string-name>, <string-name><surname>Garlena</surname><given-names>R.A.</given-names></string-name>, <string-name><surname>Mavrich</surname><given-names>T.N.</given-names></string-name>, <string-name><surname>Pope</surname><given-names>W.H.</given-names></string-name>, <string-name><surname>Reyes</surname><given-names>J.C.</given-names></string-name>, <string-name><surname>Russell</surname><given-names>D.A.</given-names></string-name>, <string-name><surname>Adair</surname><given-names>T.</given-names></string-name>, <string-name><surname>Alvey</surname><given-names>R.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Prophage-mediated defence against viral attack and viral counter-defence</article-title>. <source>Nat. Microbiol.</source><year>2017</year>; <volume>2</volume>:<fpage>16251</fpage>.<pub-id pub-id-type="pmid">28067906</pub-id></mixed-citation>
    </ref>
    <ref id="B47">
      <label>47.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Biswas</surname><given-names>A.</given-names></string-name>, <string-name><surname>Gagnon</surname><given-names>J.N.</given-names></string-name>, <string-name><surname>Brouns</surname><given-names>S.J.</given-names></string-name>, <string-name><surname>Fineran</surname><given-names>P.C.</given-names></string-name>, <string-name><surname>Brown</surname><given-names>C.M.</given-names></string-name></person-group><article-title>CRISPRTarget: bioinformatic prediction and analysis of crRNA targets</article-title>. <source>RNA Biol.</source><year>2013</year>; <volume>10</volume>:<fpage>817</fpage>–<lpage>827</lpage>.<pub-id pub-id-type="pmid">23492433</pub-id></mixed-citation>
    </ref>
    <ref id="B48">
      <label>48.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sun</surname><given-names>A.</given-names></string-name>, <string-name><surname>Li</surname><given-names>C.P.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Li</surname><given-names>D.Y.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Li</surname><given-names>L.Q.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>K.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Z.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The compact Casπ (Cas12l) ‘bracelet’ provides a unique structural platform for DNA manipulation</article-title>. <source>Cell Res.</source><year>2023</year>; <volume>33</volume>:<fpage>229</fpage>–<lpage>244</lpage>.<pub-id pub-id-type="pmid">36650285</pub-id></mixed-citation>
    </ref>
    <ref id="B49">
      <label>49.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shah</surname><given-names>S.A.</given-names></string-name>, <string-name><surname>Erdmann</surname><given-names>S.</given-names></string-name>, <string-name><surname>Mojica</surname><given-names>F.J.</given-names></string-name>, <string-name><surname>Garrett</surname><given-names>R.A.</given-names></string-name></person-group><article-title>Protospacer recognition motifs: mixed identities and functional diversity</article-title>. <source>RNA Biol.</source><year>2013</year>; <volume>10</volume>:<fpage>891</fpage>–<lpage>899</lpage>.<pub-id pub-id-type="pmid">23403393</pub-id></mixed-citation>
    </ref>
    <ref id="B50">
      <label>50.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yamada</surname><given-names>M.</given-names></string-name>, <string-name><surname>Watanabe</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Gootenberg</surname><given-names>J.S.</given-names></string-name>, <string-name><surname>Hirano</surname><given-names>H.</given-names></string-name>, <string-name><surname>Ran</surname><given-names>F.A.</given-names></string-name>, <string-name><surname>Nakane</surname><given-names>T.</given-names></string-name>, <string-name><surname>Ishitani</surname><given-names>R.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>F.</given-names></string-name>, <string-name><surname>Nishimasu</surname><given-names>H.</given-names></string-name>, <string-name><surname>Nureki</surname><given-names>O.</given-names></string-name></person-group><article-title>Crystal Structure of the Minimal Cas9 from Campylobacter jejuni Reveals the Molecular Diversity in the CRISPR-Cas9 Systems</article-title>. <source>Mol Cell</source>. <year>2017</year>; <volume>65</volume>:<fpage>1109</fpage>–<lpage>1121</lpage>.<pub-id pub-id-type="pmid">28306506</pub-id></mixed-citation>
    </ref>
    <ref id="B51">
      <label>51.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Edraki</surname><given-names>A.</given-names></string-name>, <string-name><surname>Mir</surname><given-names>A.</given-names></string-name>, <string-name><surname>Ibraheim</surname><given-names>R.</given-names></string-name>, <string-name><surname>Gainetdinov</surname><given-names>I.</given-names></string-name>, <string-name><surname>Yoon</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Song</surname><given-names>C.Q.</given-names></string-name>, <string-name><surname>Cao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Gallant</surname><given-names>J.</given-names></string-name>, <string-name><surname>Xue</surname><given-names>W.</given-names></string-name>, <string-name><surname>Rivera-Pérez</surname><given-names>J.A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A compact, high-accuracy Cas9 with a dinucleotide PAM for in vivo genome editing</article-title>. <source>Mol Cell</source>. <year>2019</year>; <volume>73</volume>:<fpage>714</fpage>–<lpage>726</lpage>.<pub-id pub-id-type="pmid">30581144</pub-id></mixed-citation>
    </ref>
    <ref id="B52">
      <label>52.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Escalona-Noguero</surname><given-names>C.</given-names></string-name>, <string-name><surname>López-Valls</surname><given-names>M.</given-names></string-name>, <string-name><surname>Sot</surname><given-names>B.</given-names></string-name></person-group><article-title>CRISPR/Cas technology as a promising weapon to combat viral infections</article-title>. <source>Bioessays</source>. <year>2021</year>; <volume>43</volume>:<fpage>e2000315</fpage>.<pub-id pub-id-type="pmid">33569817</pub-id></mixed-citation>
    </ref>
    <ref id="B53">
      <label>53.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mitchell</surname><given-names>A.L.</given-names></string-name>, <string-name><surname>Almeida</surname><given-names>A.</given-names></string-name>, <string-name><surname>Beracochea</surname><given-names>M.</given-names></string-name>, <string-name><surname>Boland</surname><given-names>M.</given-names></string-name>, <string-name><surname>Burgin</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cochrane</surname><given-names>G.</given-names></string-name>, <string-name><surname>Crusoe</surname><given-names>M.R.</given-names></string-name>, <string-name><surname>Kale</surname><given-names>V.</given-names></string-name>, <string-name><surname>Potter</surname><given-names>S.C.</given-names></string-name>, <string-name><surname>Richardson</surname><given-names>L.J.</given-names></string-name><etal>et al</etal>.</person-group><article-title>MGnify: the microbiome analysis resource in 2020</article-title>. <source>Nucleic Acids Res.</source><year>2020</year>; <volume>48</volume>:<fpage>D570</fpage>–<lpage>D578</lpage>.<pub-id pub-id-type="pmid">31696235</pub-id></mixed-citation>
    </ref>
    <ref id="B54">
      <label>54.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Konermann</surname><given-names>S.</given-names></string-name>, <string-name><surname>Lotfy</surname><given-names>P.</given-names></string-name>, <string-name><surname>Brideau</surname><given-names>N.J.</given-names></string-name>, <string-name><surname>Oki</surname><given-names>J.</given-names></string-name>, <string-name><surname>Shokhirev</surname><given-names>M.N.</given-names></string-name>, <string-name><surname>Hsu</surname><given-names>P.D.</given-names></string-name></person-group><article-title>Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors</article-title>. <source>Cell</source>. <year>2018</year>; <volume>173</volume>:<fpage>665</fpage>–<lpage>676</lpage>.<pub-id pub-id-type="pmid">29551272</pub-id></mixed-citation>
    </ref>
    <ref id="B55">
      <label>55.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kapitonov</surname><given-names>V.V.</given-names></string-name>, <string-name><surname>Makarova</surname><given-names>K.S.</given-names></string-name>, <string-name><surname>Koonin</surname><given-names>E.V.</given-names></string-name></person-group><article-title>ISC, a novel group of bacterial and archaeal DNA transposons that encode Cas9 homologs</article-title>. <source>J. Bacteriol.</source><year>2015</year>; <volume>198</volume>:<fpage>797</fpage>–<lpage>807</lpage>.<pub-id pub-id-type="pmid">26712934</pub-id></mixed-citation>
    </ref>
    <ref id="B56">
      <label>56.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koonin</surname><given-names>E.V.</given-names></string-name>, <string-name><surname>Makarova</surname><given-names>K.S.</given-names></string-name></person-group><article-title>Origins and evolution of CRISPR-Cas systems</article-title>. <source>Philos. Trans. R. Soc. Lond. B Biol. Sci.</source><year>2019</year>; <volume>374</volume>:<fpage>20180087</fpage>.<pub-id pub-id-type="pmid">30905284</pub-id></mixed-citation>
    </ref>
    <ref id="B57">
      <label>57.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Altae-Tran</surname><given-names>H.</given-names></string-name>, <string-name><surname>Kannan</surname><given-names>S.</given-names></string-name>, <string-name><surname>Demircioglu</surname><given-names>F.E.</given-names></string-name>, <string-name><surname>Oshiro</surname><given-names>R.</given-names></string-name>, <string-name><surname>Nety</surname><given-names>S.P.</given-names></string-name>, <string-name><surname>McKay</surname><given-names>L.J.</given-names></string-name>, <string-name><surname>Dlakić</surname><given-names>M.</given-names></string-name>, <string-name><surname>Inskeep</surname><given-names>W.P.</given-names></string-name>, <string-name><surname>Makarova</surname><given-names>K.S.</given-names></string-name>, <string-name><surname>Macrae</surname><given-names>R.K.</given-names></string-name><etal>et al</etal>.</person-group><article-title>The widespread IS200/IS605 transposon family encodes diverse programmable RNA-guided endonucleases</article-title>. <source>Science</source>. <year>2021</year>; <volume>374</volume>:<fpage>57</fpage>–<lpage>65</lpage>.<pub-id pub-id-type="pmid">34591643</pub-id></mixed-citation>
    </ref>
    <ref id="B58">
      <label>58.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Karvelis</surname><given-names>T.</given-names></string-name>, <string-name><surname>Druteika</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bigelyte</surname><given-names>G.</given-names></string-name>, <string-name><surname>Budre</surname><given-names>K.</given-names></string-name>, <string-name><surname>Zedaveinyte</surname><given-names>R.</given-names></string-name>, <string-name><surname>Silanskas</surname><given-names>A.</given-names></string-name>, <string-name><surname>Kazlauskas</surname><given-names>D.</given-names></string-name>, <string-name><surname>Venclovas</surname><given-names>Č.</given-names></string-name>, <string-name><surname>Siksnys</surname><given-names>V.</given-names></string-name></person-group><article-title>Transposon-associated TnpB is a programmable RNA-guided DNA endonuclease</article-title>. <source>Nature</source>. <year>2021</year>; <volume>599</volume>:<fpage>692</fpage>–<lpage>696</lpage>.<pub-id pub-id-type="pmid">34619744</pub-id></mixed-citation>
    </ref>
    <ref id="B59">
      <label>59.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Dai</surname><given-names>W.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Xie</surname><given-names>R.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Stubenrauch</surname><given-names>C.</given-names></string-name>, <string-name><surname>Lithgow</surname><given-names>T.</given-names></string-name></person-group><article-title>AcrHub: an integrative hub for investigating, predicting and mapping anti-CRISPR proteins</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D630</fpage>–<lpage>D638</lpage>.<pub-id pub-id-type="pmid">33137193</pub-id></mixed-citation>
    </ref>
    <ref id="B60">
      <label>60.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cassim</surname><given-names>N.</given-names></string-name>, <string-name><surname>Coetzee</surname><given-names>L.M.</given-names></string-name>, <string-name><surname>Stevens</surname><given-names>W.S.</given-names></string-name>, <string-name><surname>Glencross</surname><given-names>D.K.</given-names></string-name></person-group><article-title>Addressing antiretroviral therapy-related diagnostic coverage gaps across South Africa using a programmatic approach</article-title>. <source>Afr. J. Lab. Med.</source><year>2018</year>; <volume>7</volume>:<fpage>681</fpage>.<pub-id pub-id-type="pmid">30473993</pub-id></mixed-citation>
    </ref>
    <ref id="B61">
      <label>61.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Ye</surname><given-names>Y.</given-names></string-name></person-group><article-title>Not all predicted CRISPR-Cas systems are equal: isolated cas genes and classes of CRISPR like elements</article-title>. <source>BMC Bioinformatics</source>. <year>2017</year>; <volume>18</volume>:<fpage>92</fpage>.<pub-id pub-id-type="pmid">28166719</pub-id></mixed-citation>
    </ref>
    <ref id="B62">
      <label>62.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname><given-names>L.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>X.</given-names></string-name>, <string-name><surname>Li</surname><given-names>F.</given-names></string-name>, <string-name><surname>Song</surname><given-names>J.</given-names></string-name></person-group><article-title>PreAcrs: a machine learning framework for identifying anti-CRISPR proteins</article-title>. <source>BMC Bioinformatics</source>. <year>2022</year>; <volume>23</volume>:<fpage>444</fpage>.<pub-id pub-id-type="pmid">36284264</pub-id></mixed-citation>
    </ref>
    <ref id="B63">
      <label>63.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wandera</surname><given-names>K.G.</given-names></string-name>, <string-name><surname>Alkhnbashi</surname><given-names>O.S.</given-names></string-name>, <string-name><surname>Bassett</surname><given-names>H.V.I.</given-names></string-name>, <string-name><surname>Mitrofanov</surname><given-names>A.</given-names></string-name>, <string-name><surname>Hauns</surname><given-names>S.</given-names></string-name>, <string-name><surname>Migur</surname><given-names>A.</given-names></string-name>, <string-name><surname>Backofen</surname><given-names>R.</given-names></string-name>, <string-name><surname>Beisel</surname><given-names>C.L.</given-names></string-name></person-group><article-title>Anti-CRISPR prediction using deep learning reveals an inhibitor of Cas13b nucleases</article-title>. <source>Mol. Cell</source>. <year>2022</year>; <volume>82</volume>:<fpage>2714</fpage>–<lpage>2726</lpage>.<pub-id pub-id-type="pmid">35649413</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
